Author

Stephen Thomas Gately

Observed names: Gately, Stephen T., S Gately, S T Gately, S. Gately, Stephen GATELY, Stephen Gately, Stephen T. Gately

Institution: Translational Drug Development (United States)

Observed institutions: University of Notre Dame, Northwestern University, Translational Genomics Research Institute, United States Department of Veterans Affairs, University of Wisconsin–Madison, Harvard University, Duke University, Universidade de São Paulo, Veterans Health Administration, Jewish General Hospital, University of Chicago, Northwestern Memorial Hospital, Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Lady Davis Institute for Medical Research, Translational Drug Development (United States), McGill University

OpenAlex ID: A5027828131

Combined effects of angiostatin and ionizing radiation in antitumour therapy

1998 · Helena J. Mauceri, Nader N. Hanna, et al. · Nature · 668

Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy

2004 · Stephen Gately, William W Li · Seminars in Oncology · 398

The Contributions of Cyclooxygenase-2 to Tumor Angiogenesis

2000 · Stephen Gately · Cancer and Metastasis Reviews · 359

The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin

1997 · Stephen Gately, Przemyslaw Twardowski, et al. · Proceedings of the National Academy of Sciences · 292

PDF

Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor.

1990 · S S Brem, D Zagzag, et al. · Europe PMC (PubMed Central) · 231

Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin.

1996 · S Gately, P Twardowski, et al. · PubMed · 197

Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin.

1998 · D H Gorski, H J Mauceri, et al. · PubMed · 195

Novel therapeutics with enhanced biological activity generated by the strategic introduction of silicon isosteres into known drug scaffolds

2007 · Stephen Gately, Robert West · Drug Development Research · 180

β-Carboline Compounds, Including Harmine, Inhibit DYRK1A and Tau Phosphorylation at Multiple Alzheimer's Disease-Related Sites

2011 · Danielle Frost, Bessie Meechoovet, et al. · PLoS ONE · 178

PDF

Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model.

1995 · G A Soff, J Sanderowitz, et al. · Journal of Clinical Investigation · 156

PDF

Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator.

1994 · S Takano, S Gately, et al. · PubMed · 131

Antiangiogenic scheduling of lower dose cancer chemotherapy.

2001 · S Gately, R Kerbel · PubMed · 119

Therapeutic Potential of Selective Cyclooxygenase-2 Inhibitors in the Management of Tumor Angiogenesis

2003 · S. Gately, R. Kerbel · KARGER eBooks · 116

Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation

1999 · M. Sharon STACK, Stephen GATELY, et al. · Biochemical Journal · 116

PDF

Development of potent autophagy inhibitors that sensitize oncogenic BRAF V600E mutant melanoma tumor cells to vemurafenib

2014 · Megan L Goodall, Tong Wang, et al. · Autophagy · 109

Smooth muscle cell expression of type I cyclic GMP-dependent protein kinase is suppressed by continuous exposure to nitrovasodilators, theophylline, cyclic GMP, and cyclic AMP.

1997 · G A Soff, T L Cornwell, et al. · Journal of Clinical Investigation · 109

PDF

Immunolocalization of basic fibroblast growth factor to the micro vasculature of human brain tumors

1992 · Steven Brem, Ana Maria C. Tsanaclis, et al. · Cancer · 98

PDF

Human angiostatin inhibits murine hemangioendothelioma tumor growth in vivo.

1997 · B J Lannutti, S T Gately, et al. · PubMed · 94

Suramin inhibits glioma cell proliferationin vitro and in the brain

1994 · Shingo Takano, Stephen Gately, et al. · Journal of Neuro-Oncology · 42

Synthesis of Improved Lysomotropic Autophagy Inhibitors

2015 · Tong Wang, Megan L. Goodall, et al. · Journal of Medicinal Chemistry · 39

Human Microbiota and Personalized Cancer Treatments: Role of Commensal Microbes in Treatment Outcomes for Cancer Patients

2019 · Stephen Gately · Cancer treatment and research · 38

Novel silicon-containing drugs derived from the indomethacin scaffold: Synthesis, characterization and evaluation of biological activity

2006 · Galina A. Bikzhanova, Irina S. Toulokhonova, et al. · Silicon Chemistry · 30

Tumor production of angiostatin is enhanced after exposure to TNF‐α

2001 · Helena J. Mauceri, Saraswathy Seetharam, et al. · International Journal of Cancer · 27

A Pilot Trial of Pioglitazone HCl and Tretinoin in ALS: Cerebrospinal Fluid Biomarkers to Monitor Drug Efficacy and Predict Rate of Disease Progression

2012 · Todd D. Levine, Robert Bowser, et al. · Neurology Research International · 25

PDF

Statin immunolocalization in human brain tumors. Detection of noncycling cells using a novel marker of cell quiescence

1991 · Ana Maria C. Tsanaclis, Steven S. Brem, et al. · Cancer · 25

Works count: 67

Citation count: 4,110

H-index: 25

I10-index: 30